 | • レポートコード：MRC308GR01932 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（2-3営業日） • 産業分類：化学＆材料 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の医薬品用カーフィルゾミブの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の医薬品用カーフィルゾミブ市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 医薬品用カーフィルゾミブの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
医薬品用カーフィルゾミブ市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・純度≧98%、純度<98%
用途別セグメント
・注射、凍結乾燥粉末注射
主要な市場プレーヤー
・INTAS PHARMACEUTICALS LTD、BIOPHORE INDIA PHARMACEUTICALS PVT LTD、DR REDDYS LABORATORIES LTD、LAURUS LABS LTD、POLYMED THERAPEUTICS INC、FRESENIUS KABI ONCOLOGY LTD、TEVA PHARMACEUTICAL INDUSTRIES LTD、MSN LABORATORIES PRIVATE LTD、CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、医薬品用カーフィルゾミブ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医薬品用カーフィルゾミブメーカーの企業概要、2019年～2022年までの医薬品用カーフィルゾミブの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医薬品用カーフィルゾミブメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別医薬品用カーフィルゾミブの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの医薬品用カーフィルゾミブの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での医薬品用カーフィルゾミブ市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および医薬品用カーフィルゾミブの産業チェーンを掲載しています。
・第14、15章では、医薬品用カーフィルゾミブの販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
- 医薬品用カーフィルゾミブの概要
- 種類別分析（2018年vs2022年vs2029年）：純度≧98%、純度<98%
- 用途別分析（2018年vs2022年vs2029年）：注射、凍結乾燥粉末注射
- 世界の医薬品用カーフィルゾミブ市場規模・予測
- 世界の医薬品用カーフィルゾミブ生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- INTAS PHARMACEUTICALS LTD、BIOPHORE INDIA PHARMACEUTICALS PVT LTD、DR REDDYS LABORATORIES LTD、LAURUS LABS LTD、POLYMED THERAPEUTICS INC、FRESENIUS KABI ONCOLOGY LTD、TEVA PHARMACEUTICAL INDUSTRIES LTD、MSN LABORATORIES PRIVATE LTD、CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：純度≧98%、純度<98%
・用途別分析2018年-2029年：注射、凍結乾燥粉末注射
・医薬品用カーフィルゾミブの北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・医薬品用カーフィルゾミブのヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・医薬品用カーフィルゾミブのアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・医薬品用カーフィルゾミブの南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・医薬品用カーフィルゾミブの中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical Grade Carfilzomib
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pharmaceutical Grade Carfilzomib Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity≥98%
1.3.3 Purity<98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Pharmaceutical Grade Carfilzomib Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Injection
1.4.3 Freeze-dried Powder Injection
1.5 Global Pharmaceutical Grade Carfilzomib Market Size & Forecast
1.5.1 Global Pharmaceutical Grade Carfilzomib Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pharmaceutical Grade Carfilzomib Sales Quantity (2018-2029)
1.5.3 Global Pharmaceutical Grade Carfilzomib Average Price (2018-2029)
2 Manufacturers Profiles
2.1 INTAS PHARMACEUTICALS LTD
2.1.1 INTAS PHARMACEUTICALS LTD Details
2.1.2 INTAS PHARMACEUTICALS LTD Major Business
2.1.3 INTAS PHARMACEUTICALS LTD Pharmaceutical Grade Carfilzomib Product and Services
2.1.4 INTAS PHARMACEUTICALS LTD Pharmaceutical Grade Carfilzomib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 INTAS PHARMACEUTICALS LTD Recent Developments/Updates
2.2 BIOPHORE INDIA PHARMACEUTICALS PVT LTD
2.2.1 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Details
2.2.2 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Major Business
2.2.3 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Carfilzomib Product and Services
2.2.4 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Carfilzomib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Recent Developments/Updates
2.3 DR REDDYS LABORATORIES LTD
2.3.1 DR REDDYS LABORATORIES LTD Details
2.3.2 DR REDDYS LABORATORIES LTD Major Business
2.3.3 DR REDDYS LABORATORIES LTD Pharmaceutical Grade Carfilzomib Product and Services
2.3.4 DR REDDYS LABORATORIES LTD Pharmaceutical Grade Carfilzomib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 DR REDDYS LABORATORIES LTD Recent Developments/Updates
2.4 LAURUS LABS LTD
2.4.1 LAURUS LABS LTD Details
2.4.2 LAURUS LABS LTD Major Business
2.4.3 LAURUS LABS LTD Pharmaceutical Grade Carfilzomib Product and Services
2.4.4 LAURUS LABS LTD Pharmaceutical Grade Carfilzomib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 LAURUS LABS LTD Recent Developments/Updates
2.5 POLYMED THERAPEUTICS INC
2.5.1 POLYMED THERAPEUTICS INC Details
2.5.2 POLYMED THERAPEUTICS INC Major Business
2.5.3 POLYMED THERAPEUTICS INC Pharmaceutical Grade Carfilzomib Product and Services
2.5.4 POLYMED THERAPEUTICS INC Pharmaceutical Grade Carfilzomib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 POLYMED THERAPEUTICS INC Recent Developments/Updates
2.6 FRESENIUS KABI ONCOLOGY LTD
2.6.1 FRESENIUS KABI ONCOLOGY LTD Details
2.6.2 FRESENIUS KABI ONCOLOGY LTD Major Business
2.6.3 FRESENIUS KABI ONCOLOGY LTD Pharmaceutical Grade Carfilzomib Product and Services
2.6.4 FRESENIUS KABI ONCOLOGY LTD Pharmaceutical Grade Carfilzomib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 FRESENIUS KABI ONCOLOGY LTD Recent Developments/Updates
2.7 TEVA PHARMACEUTICAL INDUSTRIES LTD
2.7.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Details
2.7.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Major Business
2.7.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Carfilzomib Product and Services
2.7.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Carfilzomib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
2.8 MSN LABORATORIES PRIVATE LTD
2.8.1 MSN LABORATORIES PRIVATE LTD Details
2.8.2 MSN LABORATORIES PRIVATE LTD Major Business
2.8.3 MSN LABORATORIES PRIVATE LTD Pharmaceutical Grade Carfilzomib Product and Services
2.8.4 MSN LABORATORIES PRIVATE LTD Pharmaceutical Grade Carfilzomib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 MSN LABORATORIES PRIVATE LTD Recent Developments/Updates
2.9 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD
2.9.1 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Details
2.9.2 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Major Business
2.9.3 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Pharmaceutical Grade Carfilzomib Product and Services
2.9.4 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Pharmaceutical Grade Carfilzomib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Recent Developments/Updates
3 Competitive Environment: Pharmaceutical Grade Carfilzomib by Manufacturer
3.1 Global Pharmaceutical Grade Carfilzomib Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pharmaceutical Grade Carfilzomib Revenue by Manufacturer (2018-2023)
3.3 Global Pharmaceutical Grade Carfilzomib Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pharmaceutical Grade Carfilzomib by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pharmaceutical Grade Carfilzomib Manufacturer Market Share in 2022
3.4.2 Top 6 Pharmaceutical Grade Carfilzomib Manufacturer Market Share in 2022
3.5 Pharmaceutical Grade Carfilzomib Market: Overall Company Footprint Analysis
3.5.1 Pharmaceutical Grade Carfilzomib Market: Region Footprint
3.5.2 Pharmaceutical Grade Carfilzomib Market: Company Product Type Footprint
3.5.3 Pharmaceutical Grade Carfilzomib Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pharmaceutical Grade Carfilzomib Market Size by Region
4.1.1 Global Pharmaceutical Grade Carfilzomib Sales Quantity by Region (2018-2029)
4.1.2 Global Pharmaceutical Grade Carfilzomib Consumption Value by Region (2018-2029)
4.1.3 Global Pharmaceutical Grade Carfilzomib Average Price by Region (2018-2029)
4.2 North America Pharmaceutical Grade Carfilzomib Consumption Value (2018-2029)
4.3 Europe Pharmaceutical Grade Carfilzomib Consumption Value (2018-2029)
4.4 Asia-Pacific Pharmaceutical Grade Carfilzomib Consumption Value (2018-2029)
4.5 South America Pharmaceutical Grade Carfilzomib Consumption Value (2018-2029)
4.6 Middle East and Africa Pharmaceutical Grade Carfilzomib Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2029)
5.2 Global Pharmaceutical Grade Carfilzomib Consumption Value by Type (2018-2029)
5.3 Global Pharmaceutical Grade Carfilzomib Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2029)
6.2 Global Pharmaceutical Grade Carfilzomib Consumption Value by Application (2018-2029)
6.3 Global Pharmaceutical Grade Carfilzomib Average Price by Application (2018-2029)
7 North America
7.1 North America Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2029)
7.2 North America Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2029)
7.3 North America Pharmaceutical Grade Carfilzomib Market Size by Country
7.3.1 North America Pharmaceutical Grade Carfilzomib Sales Quantity by Country (2018-2029)
7.3.2 North America Pharmaceutical Grade Carfilzomib Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2029)
8.2 Europe Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2029)
8.3 Europe Pharmaceutical Grade Carfilzomib Market Size by Country
8.3.1 Europe Pharmaceutical Grade Carfilzomib Sales Quantity by Country (2018-2029)
8.3.2 Europe Pharmaceutical Grade Carfilzomib Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pharmaceutical Grade Carfilzomib Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pharmaceutical Grade Carfilzomib Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2029)
10.2 South America Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2029)
10.3 South America Pharmaceutical Grade Carfilzomib Market Size by Country
10.3.1 South America Pharmaceutical Grade Carfilzomib Sales Quantity by Country (2018-2029)
10.3.2 South America Pharmaceutical Grade Carfilzomib Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pharmaceutical Grade Carfilzomib Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pharmaceutical Grade Carfilzomib Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pharmaceutical Grade Carfilzomib Market Drivers
12.2 Pharmaceutical Grade Carfilzomib Market Restraints
12.3 Pharmaceutical Grade Carfilzomib Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pharmaceutical Grade Carfilzomib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pharmaceutical Grade Carfilzomib
13.3 Pharmaceutical Grade Carfilzomib Production Process
13.4 Pharmaceutical Grade Carfilzomib Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pharmaceutical Grade Carfilzomib Typical Distributors
14.3 Pharmaceutical Grade Carfilzomib Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Pharmaceutical Grade Carfilzomib Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical Grade Carfilzomib Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. INTAS PHARMACEUTICALS LTD Basic Information, Manufacturing Base and Competitors
Table 4. INTAS PHARMACEUTICALS LTD Major Business
Table 5. INTAS PHARMACEUTICALS LTD Pharmaceutical Grade Carfilzomib Product and Services
Table 6. INTAS PHARMACEUTICALS LTD Pharmaceutical Grade Carfilzomib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. INTAS PHARMACEUTICALS LTD Recent Developments/Updates
Table 8. BIOPHORE INDIA PHARMACEUTICALS PVT LTD Basic Information, Manufacturing Base and Competitors
Table 9. BIOPHORE INDIA PHARMACEUTICALS PVT LTD Major Business
Table 10. BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Carfilzomib Product and Services
Table 11. BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Carfilzomib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. BIOPHORE INDIA PHARMACEUTICALS PVT LTD Recent Developments/Updates
Table 13. DR REDDYS LABORATORIES LTD Basic Information, Manufacturing Base and Competitors
Table 14. DR REDDYS LABORATORIES LTD Major Business
Table 15. DR REDDYS LABORATORIES LTD Pharmaceutical Grade Carfilzomib Product and Services
Table 16. DR REDDYS LABORATORIES LTD Pharmaceutical Grade Carfilzomib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. DR REDDYS LABORATORIES LTD Recent Developments/Updates
Table 18. LAURUS LABS LTD Basic Information, Manufacturing Base and Competitors
Table 19. LAURUS LABS LTD Major Business
Table 20. LAURUS LABS LTD Pharmaceutical Grade Carfilzomib Product and Services
Table 21. LAURUS LABS LTD Pharmaceutical Grade Carfilzomib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. LAURUS LABS LTD Recent Developments/Updates
Table 23. POLYMED THERAPEUTICS INC Basic Information, Manufacturing Base and Competitors
Table 24. POLYMED THERAPEUTICS INC Major Business
Table 25. POLYMED THERAPEUTICS INC Pharmaceutical Grade Carfilzomib Product and Services
Table 26. POLYMED THERAPEUTICS INC Pharmaceutical Grade Carfilzomib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. POLYMED THERAPEUTICS INC Recent Developments/Updates
Table 28. FRESENIUS KABI ONCOLOGY LTD Basic Information, Manufacturing Base and Competitors
Table 29. FRESENIUS KABI ONCOLOGY LTD Major Business
Table 30. FRESENIUS KABI ONCOLOGY LTD Pharmaceutical Grade Carfilzomib Product and Services
Table 31. FRESENIUS KABI ONCOLOGY LTD Pharmaceutical Grade Carfilzomib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. FRESENIUS KABI ONCOLOGY LTD Recent Developments/Updates
Table 33. TEVA PHARMACEUTICAL INDUSTRIES LTD Basic Information, Manufacturing Base and Competitors
Table 34. TEVA PHARMACEUTICAL INDUSTRIES LTD Major Business
Table 35. TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Carfilzomib Product and Services
Table 36. TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Carfilzomib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
Table 38. MSN LABORATORIES PRIVATE LTD Basic Information, Manufacturing Base and Competitors
Table 39. MSN LABORATORIES PRIVATE LTD Major Business
Table 40. MSN LABORATORIES PRIVATE LTD Pharmaceutical Grade Carfilzomib Product and Services
Table 41. MSN LABORATORIES PRIVATE LTD Pharmaceutical Grade Carfilzomib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. MSN LABORATORIES PRIVATE LTD Recent Developments/Updates
Table 43. CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Basic Information, Manufacturing Base and Competitors
Table 44. CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Major Business
Table 45. CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Pharmaceutical Grade Carfilzomib Product and Services
Table 46. CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Pharmaceutical Grade Carfilzomib Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD Recent Developments/Updates
Table 48. Global Pharmaceutical Grade Carfilzomib Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 49. Global Pharmaceutical Grade Carfilzomib Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Pharmaceutical Grade Carfilzomib Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 51. Market Position of Manufacturers in Pharmaceutical Grade Carfilzomib, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Pharmaceutical Grade Carfilzomib Production Site of Key Manufacturer
Table 53. Pharmaceutical Grade Carfilzomib Market: Company Product Type Footprint
Table 54. Pharmaceutical Grade Carfilzomib Market: Company Product Application Footprint
Table 55. Pharmaceutical Grade Carfilzomib New Market Entrants and Barriers to Market Entry
Table 56. Pharmaceutical Grade Carfilzomib Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Pharmaceutical Grade Carfilzomib Sales Quantity by Region (2018-2023) & (Tons)
Table 58. Global Pharmaceutical Grade Carfilzomib Sales Quantity by Region (2024-2029) & (Tons)
Table 59. Global Pharmaceutical Grade Carfilzomib Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Pharmaceutical Grade Carfilzomib Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Pharmaceutical Grade Carfilzomib Average Price by Region (2018-2023) & (US$/Ton)
Table 62. Global Pharmaceutical Grade Carfilzomib Average Price by Region (2024-2029) & (US$/Ton)
Table 63. Global Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2023) & (Tons)
Table 64. Global Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2024-2029) & (Tons)
Table 65. Global Pharmaceutical Grade Carfilzomib Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Pharmaceutical Grade Carfilzomib Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Pharmaceutical Grade Carfilzomib Average Price by Type (2018-2023) & (US$/Ton)
Table 68. Global Pharmaceutical Grade Carfilzomib Average Price by Type (2024-2029) & (US$/Ton)
Table 69. Global Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2023) & (Tons)
Table 70. Global Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2024-2029) & (Tons)
Table 71. Global Pharmaceutical Grade Carfilzomib Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Pharmaceutical Grade Carfilzomib Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Pharmaceutical Grade Carfilzomib Average Price by Application (2018-2023) & (US$/Ton)
Table 74. Global Pharmaceutical Grade Carfilzomib Average Price by Application (2024-2029) & (US$/Ton)
Table 75. North America Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2023) & (Tons)
Table 76. North America Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2024-2029) & (Tons)
Table 77. North America Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2023) & (Tons)
Table 78. North America Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2024-2029) & (Tons)
Table 79. North America Pharmaceutical Grade Carfilzomib Sales Quantity by Country (2018-2023) & (Tons)
Table 80. North America Pharmaceutical Grade Carfilzomib Sales Quantity by Country (2024-2029) & (Tons)
Table 81. North America Pharmaceutical Grade Carfilzomib Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Pharmaceutical Grade Carfilzomib Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2023) & (Tons)
Table 84. Europe Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2024-2029) & (Tons)
Table 85. Europe Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2023) & (Tons)
Table 86. Europe Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2024-2029) & (Tons)
Table 87. Europe Pharmaceutical Grade Carfilzomib Sales Quantity by Country (2018-2023) & (Tons)
Table 88. Europe Pharmaceutical Grade Carfilzomib Sales Quantity by Country (2024-2029) & (Tons)
Table 89. Europe Pharmaceutical Grade Carfilzomib Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Pharmaceutical Grade Carfilzomib Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2023) & (Tons)
Table 92. Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2024-2029) & (Tons)
Table 93. Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2023) & (Tons)
Table 94. Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2024-2029) & (Tons)
Table 95. Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity by Region (2018-2023) & (Tons)
Table 96. Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity by Region (2024-2029) & (Tons)
Table 97. Asia-Pacific Pharmaceutical Grade Carfilzomib Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Pharmaceutical Grade Carfilzomib Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2023) & (Tons)
Table 100. South America Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2024-2029) & (Tons)
Table 101. South America Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2023) & (Tons)
Table 102. South America Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2024-2029) & (Tons)
Table 103. South America Pharmaceutical Grade Carfilzomib Sales Quantity by Country (2018-2023) & (Tons)
Table 104. South America Pharmaceutical Grade Carfilzomib Sales Quantity by Country (2024-2029) & (Tons)
Table 105. South America Pharmaceutical Grade Carfilzomib Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Pharmaceutical Grade Carfilzomib Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2018-2023) & (Tons)
Table 108. Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity by Type (2024-2029) & (Tons)
Table 109. Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2018-2023) & (Tons)
Table 110. Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity by Application (2024-2029) & (Tons)
Table 111. Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity by Region (2018-2023) & (Tons)
Table 112. Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity by Region (2024-2029) & (Tons)
Table 113. Middle East & Africa Pharmaceutical Grade Carfilzomib Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Pharmaceutical Grade Carfilzomib Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Pharmaceutical Grade Carfilzomib Raw Material
Table 116. Key Manufacturers of Pharmaceutical Grade Carfilzomib Raw Materials
Table 117. Pharmaceutical Grade Carfilzomib Typical Distributors
Table 118. Pharmaceutical Grade Carfilzomib Typical Customers
List of Figures
Figure 1. Pharmaceutical Grade Carfilzomib Picture
Figure 2. Global Pharmaceutical Grade Carfilzomib Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical Grade Carfilzomib Consumption Value Market Share by Type in 2022
Figure 4. Purity≥98% Examples
Figure 5. Purity<98% Examples
Figure 6. Global Pharmaceutical Grade Carfilzomib Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pharmaceutical Grade Carfilzomib Consumption Value Market Share by Application in 2022
Figure 8. Injection Examples
Figure 9. Freeze-dried Powder Injection Examples
Figure 10. Global Pharmaceutical Grade Carfilzomib Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Pharmaceutical Grade Carfilzomib Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Pharmaceutical Grade Carfilzomib Sales Quantity (2018-2029) & (Tons)
Figure 13. Global Pharmaceutical Grade Carfilzomib Average Price (2018-2029) & (US$/Ton)
Figure 14. Global Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Pharmaceutical Grade Carfilzomib Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Pharmaceutical Grade Carfilzomib by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Pharmaceutical Grade Carfilzomib Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Pharmaceutical Grade Carfilzomib Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Pharmaceutical Grade Carfilzomib Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Pharmaceutical Grade Carfilzomib Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Pharmaceutical Grade Carfilzomib Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Pharmaceutical Grade Carfilzomib Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Pharmaceutical Grade Carfilzomib Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Pharmaceutical Grade Carfilzomib Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Pharmaceutical Grade Carfilzomib Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Pharmaceutical Grade Carfilzomib Average Price by Type (2018-2029) & (US$/Ton)
Figure 29. Global Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Pharmaceutical Grade Carfilzomib Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Pharmaceutical Grade Carfilzomib Average Price by Application (2018-2029) & (US$/Ton)
Figure 32. North America Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Pharmaceutical Grade Carfilzomib Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Pharmaceutical Grade Carfilzomib Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Pharmaceutical Grade Carfilzomib Consumption Value Market Share by Region (2018-2029)
Figure 52. China Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Pharmaceutical Grade Carfilzomib Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Pharmaceutical Grade Carfilzomib Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Pharmaceutical Grade Carfilzomib Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Pharmaceutical Grade Carfilzomib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Pharmaceutical Grade Carfilzomib Market Drivers
Figure 73. Pharmaceutical Grade Carfilzomib Market Restraints
Figure 74. Pharmaceutical Grade Carfilzomib Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Pharmaceutical Grade Carfilzomib in 2022
Figure 77. Manufacturing Process Analysis of Pharmaceutical Grade Carfilzomib
Figure 78. Pharmaceutical Grade Carfilzomib Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source